Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 49.9033.3162.7566.69119.94

What is the latest Price to Cash Earnings (PCE) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 49.90 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202449.90
Mar202333.31
Mar202262.75
Mar202166.69
Mar2020119.94

How is Price to Cash Earnings (PCE) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 49.9
49.80
Mar2023 33.31
-46.92
Mar2022 62.75
-5.91
Mar2021 66.69
-44.40
Mar2020 119.94 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹38,471.6 Cr -0.6% -4.8% 27.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-0.6%

-4.8%

27.7%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses